19515-822-52 : NDC 2026 Code

19515-822-52 : Influenza Virus Vaccine ( Flulaval )

Additionally :

You can get information about “19515-822-52” NDC code in 19515-822-52 in HTML format

HTML | 19515-822-52 in TXT (Plain Text) format

TXT | 19515-822-52 in PDF (Portable Document Format)

PDF | 19515-822-52 in XML format

XML formats.

NDC Code : 19515-822-52 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "19515-822-52",
    "PackageDescription": "10 SYRINGE in 1 CARTON (19515-822-52)  / .5 mL in 1 SYRINGE (19515-822-41) ",
    "NDC11Code": "19515-0822-52",
    "ProductNDC": "19515-822",
    "ProductTypeName": "VACCINE",
    "ProprietaryName": "Flulaval",
    "ProprietaryNameSuffix": "2026/2027",
    "NonProprietaryName": "Influenza Virus Vaccine",
    "DosageFormName": "SUSPENSION",
    "RouteName": "INTRAMUSCULAR",
    "StartMarketingDate": "20260701",
    "EndMarketingDate": "20270630",
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA125163",
    "LabelerName": "ID Biomedical Corporation of Quebec",
    "SubstanceName": "INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR 278 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN 049A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)",
    "StrengthNumber": "15; 15; 15",
    "StrengthUnit": "ug/.5mL; ug/.5mL; ug/.5mL",
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-07-14",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20260701",
    "EndMarketingDatePackage": "20270630",
    "SamplePackage": "N"
  }
}